We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6762:TSETDK Corporation Analysis

Data as of 2026-03-10 - not real-time

¥2,208.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

TDK’s share price sits above its long‑term moving average yet remains under the short‑term average, indicating a modest upside potential while short‑term momentum is subdued. The RSI hovers near the neutral midpoint and the MACD histogram is negative, pointing to bearish short‑term pressure despite a broadly bullish trend classification. Beta below one suggests the stock moves less sharply than the market, but a 30‑day volatility reading is markedly high, highlighting price swings. Valuation metrics are attractive: the price‑to‑earnings multiple is well below the industry average and the implied upside from discounted cash‑flow analysis is positive, while the dividend yield is modest with a payout ratio comfortably under 40%. Fundamentally, revenue growth remains strong, margins are solid, and cash on hand exceeds total debt, providing a resilient balance sheet. The recent establishment of an Asia‑Pacific regional headquarters in Bengaluru underscores a strategic push into high‑growth markets, enhancing geographic diversification. Overall, the blend of undervalued pricing, stable cash generation, and strategic expansion supports a positive outlook, though short‑term technical weakness advises caution.
In the near term, the proximity to a key support level and bearish momentum temper enthusiasm, but the medium‑ to long‑term narrative is buoyed by solid fundamentals, dividend sustainability, and growth‑oriented initiatives.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near a defined support level
  • bearish MACD histogram
  • stable trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation advantage versus industry peers
  • robust revenue growth and margin profile
  • sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • strong cash generation and net cash position
  • strategic expansion through new APAC headquarters
  • steady dividend and attractive long‑term valuation

Key Metrics & Analysis

Financial Health

Revenue Growth16.20%
Profit Margin7.84%
P/E Ratio24.3
ROE9.52%
ROA3.73%
Debt/Equity32.97
P/B Ratio2.0
Op. Cash Flow¥430.0B
Free Cash Flow¥26.9B
Industry P/E36.9

Technical Analysis

TrendBullish
RSI49.1
Support¥2,002.00
Resistance¥2,498.00
MA 20¥2,278.75
MA 50¥2,169.27
MA 200¥2,045.59
MACDBearish
VolumeStable
Fear & Greed Index78.04

Valuation

Fair Value¥480.81
Target Price¥2,641.18
Upside/Downside19.62%
GradeUndervalued
TypeBlend
Dividend Yield1.62%

Risk Assessment

Beta0.91
Volatility64.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.